Escitalopram
- Product NDC
- 68180-136
- 11-digit product format
- 681800136
- Labeler code
- 68180
- Product ID
- 68180-136_bd9ecc53-f6db-4750-8d73-6081cf03afa0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Escitslopram
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA078169
- Marketing category
- ANDA
- Marketing start
- 2012-09-10
- Marketing end
- 0000-00-00
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-136-01 | Escitalopram | 100 in 1 BOTTLE | TABLET | 100 | | 21 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ESCITALOPRAM OXALATE | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| ESCITALOPRAM | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 11 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-136 | ESCITALOPRAM (ESCITSLOPRAM) TABLET [LUPIN PHARMACEUTICALS, INC.] | 21 | Legacy NDC, 1 package rows | 20231219_41f7392a-1f5c-4542-9c5c-f9e109851381.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-136-01 | 68180013601 | 100 TABLET in 1 BOTTLE (68180-136-01) | 100 tablet | 2012-09-10 | 0000-00-00 | No | No | Current |